Miele, G.; Cepparulo, S.; Abbadessa, G.; Lavorgna, L.; Sparaco, M.; Simeon, V.; Guizzaro, L.; Bonavita, S.
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study. J. Clin. Med. 2023, 12, 1023.
https://doi.org/10.3390/jcm12031023
AMA Style
Miele G, Cepparulo S, Abbadessa G, Lavorgna L, Sparaco M, Simeon V, Guizzaro L, Bonavita S.
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study. Journal of Clinical Medicine. 2023; 12(3):1023.
https://doi.org/10.3390/jcm12031023
Chicago/Turabian Style
Miele, Giuseppina, Simone Cepparulo, Gianmarco Abbadessa, Luigi Lavorgna, Maddalena Sparaco, Vittorio Simeon, Lorenzo Guizzaro, and Simona Bonavita.
2023. "Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study" Journal of Clinical Medicine 12, no. 3: 1023.
https://doi.org/10.3390/jcm12031023
APA Style
Miele, G., Cepparulo, S., Abbadessa, G., Lavorgna, L., Sparaco, M., Simeon, V., Guizzaro, L., & Bonavita, S.
(2023). Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study. Journal of Clinical Medicine, 12(3), 1023.
https://doi.org/10.3390/jcm12031023